Peng Qing-Hua, Yao Xiao-Lei, Wu Quan-Long, Tan Han-Yu, Zhang Jing-Rong
Key Discipline of Traditional Chinese Ophthalmology, the First Affiliated Hospital of Hunan University of Traditional Chinese Medicine, Changsha 410007, Hunan Province, China.
Int J Ophthalmol. 2010;3(1):43-8. doi: 10.3980/j.issn.2222-3959.2010.01.10. Epub 2010 Mar 18.
To evaluate the effects of the extract of Buddleja officinalis eye drops in basic tears secretory volume, tear film stability, expression of androgen receptors (AR) in castrated rats with dry eye, and to investigate the therapeutic effects of the extract of Buddleja officinalis on dry eye caused by gonadal hormones level imbalance.
Forty-five Wistar masculinity rats were divided at random into nine groups, including normal groups (A1, A2 and A3); model groups (B1, B2 and B3); therapy groups with extract of Buddleja officinalis eye drops (C1, C2 and C3). The "1" stood for being fed for 1 month, and "2" for 2 months, and "3" for 3 months. The dry eye model was established with orchiectomy on groups B and C. Group C was treated with Buddleja officinalis extract eye drops for one month. All rats were checked with Schirmer I test (SIT) and tear film break-up time (BUT). Expression of AR was analyzed by flow cytometer (FCM).
The SIT value of group C was significantly higher than that of group B (P<0.01) and the BUT value of group C was significantly longer than that of group B (P<0.01), which indicated the eye drop could significantly keep basic tears secretory volume and tear film stability. And the expression of AR of group C was much higher than that of group B, which showed that available composition of the eye drops maybe display androgen-like activity.
The main components of the extract of Buddleja officinalis is the flavonoids that can significantly inhibit happening of dry eye of rat after androgen level lowered. Its mechanism is like androgen's and it can display androgen-like activity to keep basic tears secretory volume and tear film stability.
评价密蒙花提取物滴眼液对去势干眼大鼠基础泪液分泌量、泪膜稳定性及雄激素受体(AR)表达的影响,探讨密蒙花提取物对性腺激素水平失衡所致干眼的治疗作用。
45只雄性Wistar大鼠随机分为9组,包括正常组(A1、A2和A3);模型组(B1、B2和B3);密蒙花提取物滴眼液治疗组(C1、C2和C3)。“1”代表喂养1个月,“2”代表喂养2个月,“3”代表喂养3个月。对B组和C组大鼠行睾丸摘除术建立干眼模型。C组用密蒙花提取物滴眼液治疗1个月。所有大鼠均行Schirmer I试验(SIT)和泪膜破裂时间(BUT)检查。采用流式细胞仪(FCM)分析AR表达。
C组SIT值显著高于B组(P<0.01),C组BUT值显著长于B组(P<0.01),表明该滴眼液能显著维持基础泪液分泌量和泪膜稳定性。且C组AR表达明显高于B组,表明滴眼液有效成分可能具有类雄激素活性。
密蒙花提取物主要成分为黄酮类化合物,可显著抑制雄激素水平降低后大鼠干眼的发生。其作用机制与雄激素相似,可发挥类雄激素活性,维持基础泪液分泌量和泪膜稳定性。